Patents by Inventor Tsampikos Dimitrios PANAGIOTOPOULOS

Tsampikos Dimitrios PANAGIOTOPOULOS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oral solutions comprising fludrocortisone acetate
    Patent number: 11771706
    Abstract: Physicochemically stable oral pharmaceutical solution comprising fludrocortisone acetate and a non-aqueous liquid carrier comprising one or more medium-chain fatty acid triglycerides.
    Type: Grant
    Filed: February 12, 2021
    Date of Patent: October 3, 2023
    Assignee: LABOMED PHARMACEUTICAL COMPANY S.A.
    Inventors: Georgios Liolios, Tsampikos Dimitrios Panagiotopoulos, Konstantinos Pachis
  • ORAL SOLUTIONS COMPRISING FLUDROCORTISONE ACETATE
    Publication number: 20210260077
    Abstract: Physicochemically stable oral pharmaceutical solution comprising fludrocortisone acetate and a non-aqueous liquid carrier comprising one or more medium-chain fatty acid triglycerides.
    Type: Application
    Filed: February 12, 2021
    Publication date: August 26, 2021
    Applicant: LABOMED PHARMACEUTICAL COMPANY S.A.
    Inventors: Georgios LIOLIOS, Tsampikos Dimitrios PANAGIOTOPOULOS, Konstantinos PACHIS
  • ORAL COMPOSITIONS COMPRISING METHYLPREDNISOLONE SODIUM SUCCINATE
    Publication number: 20210161822
    Abstract: Stable, non-caking, pharmaceutical composition in the form of powder for oral solution comprising methylprednisolone sodium succinate and methods of making such compositions. The compositions comprise lyophilized methylprednisolone sodium succinate mixed with one or more water-soluble pharmaceutically acceptable excipients.
    Type: Application
    Filed: June 18, 2019
    Publication date: June 3, 2021
    Applicant: DOCU-MED LIMITED
    Inventors: Tsampikos Dimitrios PANAGIOTOPOULOS, Soultana TZIALA